These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 1324710)
1. Purification and characterization of a novel growth factor from human breast cancer cells. Lupu R; Wellstein A; Sheridan J; Ennis BW; Zugmaier G; Katz D; Lippman ME; Dickson RB Biochemistry; 1992 Aug; 31(32):7330-40. PubMed ID: 1324710 [TBL] [Abstract][Full Text] [Related]
2. The role of erbB-2 and its ligands in growth control of malignant breast epithelium. Lupu R; Dickson RB; Lippman ME Princess Takamatsu Symp; 1991; 22():49-60. PubMed ID: 1688228 [TBL] [Abstract][Full Text] [Related]
3. Colorectum cell-derived growth factor (CRDGF) is homologous to amphiregulin, a member of the epidermal growth factor family. Culouscou JM; Remacle-Bonnet M; Carlton GW; Plowman GD; Shoyab M Growth Factors; 1992; 7(3):195-205. PubMed ID: 1333777 [TBL] [Abstract][Full Text] [Related]
4. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha. Ethier SP; Langton BC; Dilts CA Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580 [TBL] [Abstract][Full Text] [Related]
5. Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2. Lupu R; Colomer R; Zugmaier G; Sarup J; Shepard M; Slamon D; Lippman ME Science; 1990 Sep; 249(4976):1552-5. PubMed ID: 2218496 [TBL] [Abstract][Full Text] [Related]
6. The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468. Modjtahedi H; Styles JM; Dean CJ Br J Cancer; 1993 Feb; 67(2):247-53. PubMed ID: 8094290 [TBL] [Abstract][Full Text] [Related]
7. Differential activation of ErbB receptors in the rat olfactory mucosa by transforming growth factor-alpha and epidermal growth factor in vivo. Ezeh PI; Farbman AI J Neurobiol; 1998 Nov; 37(2):199-210. PubMed ID: 9805267 [TBL] [Abstract][Full Text] [Related]
8. Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses. Lupu R; Colomer R; Kannan B; Lippman ME Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2287-91. PubMed ID: 1347947 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor (EGF)- and transforming growth factor alpha-stimulated invasion and growth of follicular thyroid cancer cells can be blocked by antagonism to the EGF receptor and tyrosine kinase in vitro. Hölting T; Siperstein AE; Clark OH; Duh QY Eur J Endocrinol; 1995 Feb; 132(2):229-35. PubMed ID: 7858744 [TBL] [Abstract][Full Text] [Related]
10. The binding of HB-EGF to tumour cells is blocked by mAbs which act as EGF and TGF alpha antagonists. Modjtahedi H; Dean C Biochem Biophys Res Commun; 1995 Feb; 207(1):389-97. PubMed ID: 7857293 [TBL] [Abstract][Full Text] [Related]
11. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A. Yamada Y; Serrero G J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor and transforming growth factor alpha bind differently to the epidermal growth factor receptor. Winkler ME; O'Connor L; Winget M; Fendly B Biochemistry; 1989 Jul; 28(15):6373-8. PubMed ID: 2790004 [TBL] [Abstract][Full Text] [Related]
13. Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours. Modjtahedi H; Komurasaki T; Toyoda H; Dean C Int J Cancer; 1998 Jan; 75(2):310-6. PubMed ID: 9462724 [TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of heparin-binding growth factors from porcine uterus. Brigstock DR; Heap RB; Barker PJ; Brown KD Biochem J; 1990 Feb; 266(1):273-82. PubMed ID: 2310377 [TBL] [Abstract][Full Text] [Related]
15. Contribution of the transforming growth factor alpha B-loop beta-sheet to binding and activation of the epidermal growth factor receptor. Richter A; Drummond DR; MacGarvie J; Puddicombe SM; Chamberlin SG; Davies DE J Biol Chem; 1995 Jan; 270(4):1612-6. PubMed ID: 7829492 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor alpha, but not epidermal growth factor, promotes the survival of sensory neurons in vitro. Chalazonitis A; Kessler JA; Twardzik DR; Morrison RS J Neurosci; 1992 Feb; 12(2):583-94. PubMed ID: 1740693 [TBL] [Abstract][Full Text] [Related]
17. Neural and glial-mediated effects of growth factors acting via tyrosine kinase receptors on luteinizing hormone-releasing hormone neurons. Voigt P; Ma YJ; Gonzalez D; Fahrenbach WH; Wetsel WC; Berg-von der Emde K; Hill DF; Taylor KG; Costa ME; Seidah NG; Ojeda SR Endocrinology; 1996 Jun; 137(6):2593-605. PubMed ID: 8641214 [TBL] [Abstract][Full Text] [Related]
18. Partial characterization of a unique mitogenic activity secreted by rat Sertoli cells. Lamb DJ; Spotts GS; Shubhada S; Baker KR Mol Cell Endocrinol; 1991 Aug; 79(1-3):1-12. PubMed ID: 1936536 [TBL] [Abstract][Full Text] [Related]
19. A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling. Moriai T; Kobrin MS; Hope C; Speck L; Korc M Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10217-21. PubMed ID: 7937865 [TBL] [Abstract][Full Text] [Related]
20. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. Higashiyama S; Lau K; Besner GE; Abraham JA; Klagsbrun M J Biol Chem; 1992 Mar; 267(9):6205-12. PubMed ID: 1556128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]